We identify potential investments through deep sector research and assess our capability in full partnership with their management teams to build market-leading and innovative companies.
2022
LXO Group is a leading specialty pharma platform with market differentiating capabilities in Late Lifecycle Management, Digital,
in-licensing and M&A
2022
Qinecsa is a leading global provider of pharmacovigilance software and outsourced services to support its global pharma customers across their clinical safety and PV commitments.
2022
Arietta.AI is an expert in crafting transformative AI solutions for life sciences companies.
2020
Noden Pharma DAC is a global specialty pharmaceutical company that is focused on acquiring prescription medicines across a broad range of therapeutic areas in international markets. The company focuses its resources on acquiring and optimizing established medicines.
2020
Essential is a portfolio company of a European focused private equity fund. Simon Cottle led the origination of the investment in the company and was co-lead on the execution of the transaction